STRM.BIO
Laura Goldberg has a work experience that includes roles such as VP of Research and Development at STRM.BIO starting from July 2022, Senior Director of Research from June 2021 to July 2022, Director of Research from March 2021 to June 2021, and Director of Research-Consultant from October 2020 to March 2021. Laura has also worked as an Assistant Professor and Member of the Faculty at Harvard Medical School from August 2019 to October 2020. Additionally, they worked as a Hematologist at Brigham and Women's Hospital from August 2019 to March 2021 and as an Assistant Professor of Medicine at The Warren Alpert Medical School of Brown University from July 2011 to July 2019.
Laura Goldberg completed their Bachelor of Arts degree in Biology, General at Carleton College. Laura then pursued a MDPhD degree in Molecular Genetics and Biochemistry, Medicine at the University of Pittsburgh. Subsequently, they completed a fellowship in Hematology/Oncology at The Warren Alpert Medical School of Brown University. Laura Goldberg has also obtained certifications in Hematology and Oncology from the American Board of Internal Medicine.
This person is not in any offices
STRM.BIO
Based in Boston, MA, STRM.BIO (“storm bio”) is a pre-clinical, VC-backed biotechnology company that aims to fulfill the promise of gene therapy by leveraging extracellular vesicles (EVs) to deliver treatment directly to the patient (in vivo). Unlike viruses, EVs are natural carriers of nucleic acids and proteins with innate targeting capabilities, amenability to large scale/commercial manufacture, and low immunogenicity – which make them excellent cell messengers for gene therapies. Our proprietary EV platform is establishing a whole new class of therapeutics, yielding new therapies and making existing ones more effective. At STRM.BIO, we believe that our work has the potential to democratize gene therapy and bring hope for patients fighting rare diseases worldwide. We are currently recruiting team members who can help us make our vision a life-saving reality.